Report Type : Therapy Reports
Report Category : Oncology
Report Subcategory : Multiple Myeloma or Kahler Disease
Price : 1999.00
Date : October 2023
Multiple Myeloma Global Market Landscape till 2030 : Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing
Multiple Myeloma or Kahler Disease:
Multiple myeloma cells are abnormal plasma cells (a type of white blood cell) that build up in the bone marrow and form tumors in many bones of the body. Normal plasma cells make antibodies to help the body fight infection and disease. As the number of multiple myeloma cells increases, more antibodies are made. This can cause the blood to thicken and keep the bone marrow from making enough healthy blood cells. Multiple myeloma cells also damage and weaken the bone.
Top & Promising Drugs by Company: